HER1, HER2, HER3 and HER4 gene copy number and protein expression in non-small cell lung cancer

被引：0
|
作者：
Jeon, Y. [1 ]
Kim, Y. [1 ]
Sung, S. [1 ]
Seo, J. [1 ]
Chung, D. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Boramae Hosp, Seoul Natl Univ Hosp,Dept Pathol & Thorac Surg, Seoul, South Korea
来源：
HISTOPATHOLOGY | 2008年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
804
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [41] Detection of EGFR, HER2, HER3 and HER4 homodimerization and heterodimerization using EFC-based cellular assays
    Lamerdin, Jane
    Saharia, Abhishek
    Lin-Jones, Jennifer
    Nguyen, Mimi
    Fabionar, Hyna
    Gunturi, Sangeetha
    Srivastava, Abha
    Wehrman, Tom
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Axonal neuregulin signals the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3
    Vartanian, T
    Goodearl, A
    Viehover, A
    Lees, M
    Fischbach, G
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S121 - S121
  • [43] Screening for HER2 alterations and HER2-targeted therapy in non-small cell lung cancer
    Kinoshita, Ichiro
    ANNALS OF ONCOLOGY, 2015, 26 : 40 - 40
  • [44] Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, breast cancer progression, and HER2 inhibitor sensitivity
    Hanker, Ariella B.
    Jayanthan, Harikrishna Sekar
    Ye, Dan
    Lin, Chang-Ching
    Akamatsu, Hiroaki
    Sheehan, Jonathan H.
    Koch, James P.
    Sudhan, Dhivya R.
    Brewer, Monica Red
    Servetto, Alberto
    He, Jie
    Miller, Vincent A.
    Lalani, Alshad S.
    Meiler, Jens
    Arteaga, Carlos L.
    CANCER RESEARCH, 2020, 80 (04)
  • [45] Targeting HER2 in the treatment of non-small cell lung cancer
    Mar, Nataliya
    Vredenburgh, James J.
    Wasser, Jeffrey S.
    LUNG CANCER, 2015, 87 (03) : 220 - 225
  • [46] Investigation of HER2 overexpression in non-small cell lung cancer
    Ugocsai, K
    Mándoky, L
    Tiszlavicz, L
    Molnár, J
    ANTICANCER RESEARCH, 2005, 25 (04) : 3061 - 3066
  • [47] A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
    Mota, Jose Mauricio
    Collier, Katharine Ann
    Costa, Ricardo Lima Barros
    Taxter, Timothy
    Kalyan, Aparna
    Leite, Caio A.
    Chae, Young Kwang
    Giles, Francis J.
    Carneiro, Benedito A.
    ONCOTARGET, 2017, 8 (51) : 89284 - 89306
  • [48] Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3
    Vartanian, T
    Goodearl, A
    Viehover, A
    Fischbach, G
    JOURNAL OF CELL BIOLOGY, 1997, 137 (01): : 211 - 220
  • [49] Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer
    Yun, Chen
    Gang, Li
    Gu Rongmin
    Xu, Wen
    Ming Xuezhi
    Chen Huanqiu
    MOLECULAR CARCINOGENESIS, 2015, 54 (12) : 1700 - 1709
  • [50] Correlation between epidermal growth factor receptor family (HER1, HER2, HER3, HER4), phosphorylated akt (P-Akt) and clinical outcomes after radiation therapy in carcinoma of the cervix
    Lee, CM
    Shrieve, DC
    Zempolich, KA
    Lee, RJ
    Handrahan, DL
    Hammond, E
    Gaffney, DK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S483 - S483
12345